Literature DB >> 11039419

Primary vitrectomy alone for repair of retinal detachments following cataract surgery.

M A Speicher1, A D Fu, J P Martin, M A von Fricken.   

Abstract

PURPOSE: To report the visual, anatomic, and refractive results of primary vitrectomy alone for the repair of retinal detachments (RD) following cataract surgery.
METHODS: Retrospective review of office charts and operative reports of 83 eyes.
RESULTS: A minimum of 4 months' follow-up was achieved for 78 pseudophakic or aphakic eyes that underwent primary vitrectomy, internal drainage of subretinal fluid, retinopexy, and intravitreal gas injection for RD repair. Anatomic reattachment was achieved in 93.6% of cases after one procedure and in 96.2% eventually. Median preoperative Snellen acuity was 20/200 and increased to 20/25 at final examination. For the 45 eyes with macula-off detachments, 80% achieved final acuities greater than or equal to 20/40. The average refractive change following surgery was -0.11 diopters. Transient postoperative ocular hypertension was seen in 17.9% and proliferative vitreoretinopathy with recurrent RD in 5.1%.
CONCLUSION: Primary pars plana vitrectomy is a highly effective treatment modality for the repair of RD following cataract surgery, and appears to be refractively neutral.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039419     DOI: 10.1097/00006982-200009000-00005

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  25 in total

Review 1.  View 3: The case for pneumatic retinopexy.

Authors:  E R Holz; W F Mieler
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

Review 2.  View 2: the case for primary vitrectomy.

Authors: 
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

Review 3.  [Vitrectomy with or without cerclage in the treatment of retinal detachment].

Authors:  F Ziemssen; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

4.  Tailored vitrectomy and laser photocoagulation without scleral buckling for all primary rhegmatogenous retinal detachments.

Authors:  K Johansson; M Malmsjö; F Ghosh
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

5.  Pseudophakic rhegmatogenous retinal detachment: combined pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone.

Authors:  Rivka Kessner; Adiel Barak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-01       Impact factor: 3.117

6.  Primary vitrectomy for rhegmatogenous retinal detachment: an analysis of 512 cases.

Authors:  Heinrich Heimann; Xiulan Zou; Claudia Jandeck; Ulrich Kellner; Nikolaos E Bechrakis; Klaus-Martin Kreusel; Horst Helbig; Lothar Krause; Andreas Schüler; Norbert Bornfeld; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-26       Impact factor: 3.117

7.  Primary vitrectomy with short-term silicone oil tamponade for uncomplicated rhegmatogenous retinal detachment.

Authors:  Murat Karacorlu; Mumin Hocaoglu; Isil Sayman Muslubas; M Giray Ersoz; Serra Arf; Omer Uysal
Journal:  Int Ophthalmol       Date:  2017-12-18       Impact factor: 2.031

8.  A possible strategic role of air during pars plana vitrectomy for macula-involving rhegmatogenous retinal detachment.

Authors:  Rino Frisina; Irene Gius; Giuseppe Frascogna; Tobia Pizzolon; Angelo Greggio; Luigi Tozzi; Edoardo Midena
Journal:  Int Ophthalmol       Date:  2020-09-20       Impact factor: 2.031

9.  The fate of Müller's glia following experimental retinal detachment: nuclear migration, cell division, and subretinal glial scar formation.

Authors:  Geoffrey P Lewis; Ethan A Chapin; Gabriel Luna; Kenneth A Linberg; Steven K Fisher
Journal:  Mol Vis       Date:  2010-07-15       Impact factor: 2.367

10.  Primary 25-gauge transconjunctival sutureless vitrectomy in pseudophakic retinal detachment.

Authors:  Fatih Horozoglu; Ates Yanyali; Erkan Celik; Banu Aytug; Ahmet F Nohutcu
Journal:  Indian J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.